Pantherna Therapeutics to be granted 2.2 millions EFRE public funding.

Pantherna Therapeutics GmbH secured a successful grant of 2.2 Million EUR by the EU and the Brandenburg state. The funding is within the framework of EFRE and will support Pantherna’s research and development program ‘Vascular specific carrier Systems’. This ongoing project is scheduled until the end of 2022.